Safetytech Logo

Webinar Replay and Highlights: Reducing Musculoskeletal Disorders (MSDs) in Safety-Critical Industries

03/12/2024

On November 26th 2024 we held a webinar focused on how emerging technologies are helping to reduce MSD rates in safety-Critical industries, while also delivering notable improvements in productivity and cost savings.

As technological advancements continue to shape the landscape of industrial safety, we’re seeing new opportunities to address musculoskeletal disorders (MSDs) more effectively.

Safetytech Accelerator recently released a report ‘Tackling MSD in Industrial Sectors with Emerging Tech‘. This report provides an in-depth analysis of emerging technologies addressing this issue. It also features real-world examples where companies have successfully implemented solutions such as AI, robotics, wearables, and exoskeletons, resulting in measurable reductions in injury risks, improved productivity, and cost savings.

Find out more and download the report, click here

Or fill in the form below to watch the webinar recording.

 

What You’ll Learn:

  • How new technologies are impacting MSD prevention and safety in industrial settings.
  • Key barriers and opportunities, featuring insights from industry experts, regulatory voices, and technology innovators.
  • Practical guidance on evaluating MSD safety tech solutions.

 

Agenda:

Introduction by Helen Evans, Head of Market Development at Safetytech Accelerator, followed by a panel discussion with representatives from industry, technology, and regulatory sectors.

 

Panellists:

Matthew Birtles | HF Team Leader, Health and Safety Executive, Science Division
Anna Rowland | Group Physical Health Lead, National Grid
Bryan Statham | CEO, LifeBooster Inc.

 

Who Should Watch:

This webinar is ideal for safety professionals, industrial leaders, and technology innovators interested in reducing MSD risks and fostering safer, more productive work environments.

 

 

Drop your details into this form to watch the webinar

  • This field is for validation purposes and should be left unchanged.